Join

Compare · APR vs BAX

APR vs BAX

Side-by-side comparison of Apria Inc. (APR) and Baxter International Inc. (BAX): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both APR and BAX operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
  • BAX is the larger of the two at $42.70B, about 32.3x APR ($1.32B).
  • BAX has hit the wire 5 times in the past 4 weeks while APR has been quiet.
  • BAX has more recent analyst coverage (25 ratings vs 6 for APR).
MetricAPRBAX
Company
Apria Inc.
Baxter International Inc.
Price
$37.49-0.01%
$18.15-1.44%
Market cap
$1.32B
$42.70B
1M return
-
+5.95%
1Y return
-
-40.53%
Industry
Medical/Dental Instruments
Medical/Dental Instruments
Exchange
NASDAQ
NYSE
IPO
2021
News (4w)
0
5
Recent ratings
6
25
APR

Apria Inc.

Apria, Inc. provides integrated home healthcare equipment and related services in the United States. The company offers home respiratory therapies, including the supply of stationary and portable home oxygen equipment, and non-invasive ventilators; obstructive sleep apnea therapy devices comprising continuous positive airway pressure and bi-level positive airway pressure devices, and patient support services; and negative pressure wound therapy products. It also provides a range of home medical equipment and other products, and services for patients with home care needs; and clinical and administrative support services, and related products and supplies to patients. The company was incorporated in 2018 and is headquartered in Indianapolis, Indiana.

BAX

Baxter International Inc.

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; renal replacement therapies and other organ support therapies focused in the intensive care unit; sterile intravenous (IV) solutions, IV therapies, infusion pumps, administration sets, and drug reconstitution devices; and parenteral nutrition therapies. It also provides biological products and medical devices, and surgical hemostat and sealant products used in surgical procedures for hemostasis, tissue sealing, and adhesion prevention; premixed and oncology drug platforms, inhaled anesthesia and critical care products, and pharmacy compounding services; and generic injectable pharmaceuticals. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules. Baxter International Inc. was founded in 1931 and is headquartered in Deerfield, Illinois.

Latest APR

Latest BAX